Announces updated national, state, and Congressional District polling relevant to priority issues.
Statement outlines specific solutions to patient-manipulation by “PBMs”.
NACDS stands up for seniors and pharmacies in comments on Medicare proposed rule.
NACDS insists that comprehensive DIR fee reform now depends on further legislative and regulatory action to improve predictability, fairness, and viability for pharmacies.
Groups applaud CMS’ ongoing efforts to address DIR fees; urge further action for comprehensive pharmacy DIR reform that “reduce[s] [Medicare] beneficiary drug costs and also protect[s] pharmacy access”.
Calls on the Center for Medicare and Medicaid Innovation to integrate pharmacies and pharmacists into value-based programs and alternative payment models to accelerate mission toward better outcomes and lower costs.
NACDS today said that omitting pharmacy direct and indirect remuneration (DIR) fee reforms from the Build Back Better Act budget reconciliation bill will deprive Medicare beneficiaries of between $7.1 and $9.2 billion over 10 years in reduced cost-sharing for prescription drugs, according to Centers for Medicare and Medicaid Services (CMS) estimates.
249 organizations sign letter urging Congress to reduce senior drug costs by addressing backdoor pharmacy price concessions.
Direct and indirect remuneration (DIR) fees continue to rise at an alarming rate, inflating seniors’ out-of-pocket prescription drug costs and jeopardizing the viability of pharmacies and patient access.
Urges Congress to pass legislation to reduce patients’ out-of-pocket costs and to prevent pharmacy closures jeopardizing patient access.
